Search results
Results from the WOW.Com Content Network
In 2010, guanfacine was approved by the FDA for the treatment of attention deficit hyperactivity disorder for people 6 to 17 years old. [16] It was approved for ADHD by the European Medicines Agency under the name Intuniv in 2015. [61] It was added to the Australian Pharmaceutical Benefits Scheme for the treatment of ADHD in 2018. [62]
Guaifenesin, also known as glyceryl guaiacolate, is an expectorant medication taken by mouth and marketed as an aid to eliminate sputum from the respiratory tract. Chemically, it is an ether of guaiacol and glycerine .
The Child Behavior Checklist (CBCL) is a widely used caregiver report form identifying problem behavior in children. [ 1 ] [ 2 ] It is widely used in both research and clinical practice with youths. It has been translated into more than 90 languages, [ 3 ] and normative data are available integrating information from multiple societies.
The 86-item questionnaire has separate forms for parents and teachers, and typically takes 10–15 minutes to administer and 15–20 minutes to score. Other versions of the BRIEF also exist for preschool children aged 2–5 (BRIEF-P), self-reports of adolescents aged 11–18 (BRIEF-SR), and self/informant-reports of adults aged 18–90 (BRIEF-A).
Guaifenesin/codeine is a fixed-dose combination cold medicine used for the treatment of cough. [1] It contains guaifenesin, an expectorant; and codeine, as the phosphate, an opioid antitussive. [1] It is taken by mouth. [1] It was approved for medical use in the United States in 2006. [1]
This page was last edited on 21 December 2023, at 22:50 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
The schedules for older children became the property of Gesell Institute of Child Development which was established in 1950. In 1964 Dr. Francis Ilg and Dr. Louise Bates Ames, the founders of the Gesell Institute, refined, revised, and collected data on children 5–10 years of age and subsequently in 1965, 1972, and 1979. The results were ...
In the release contingency condition, children were not released from time-out if they were performing problem behavior during the last 30 seconds of their time-out. The time-out was extended until there were no occurrences of problem behavior for a total of 30 seconds or until the time-out reached the ten-minute mark.